FDA Approved: IMULDOSA — Original Application (Accord BioPharma Inc.)

View source ↗

Summary

The FDA approves Imuldosa (ustekinumab-srlf) from Accord BioPharma Inc. under an Original Biologics License Application, expanding treatment options for plaque …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Plaque Psoriasis
• Psoriatic Arthritis
• Ulcerative Colitis

Drugs mentioned

• IMULDOSA (ustekinumab-srlf)

Snippet

ORIG AP for IMULDOSA (USTEKINUMAB-SRLF)